These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 323093)

  • 41. Plethysmographic confirmation of the beneficial effect of calcium dobesilate in primary varicose veins.
    Androulakis G; Panoysis PA
    Angiology; 1989 Jan; 40(1):1-4. PubMed ID: 2642669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Calcium dobesilate in the treatment of primary venous insufficiency of the lower limbs. A controlled clinical study].
    Pecchi S; De Franco V; Damiani P; Guerrini M; Di Perri T
    Clin Ter; 1990 Mar; 132(6):409-17. PubMed ID: 2139387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma.
    Vojnikovic B
    Ophthalmic Res; 1991; 23(1):12-20. PubMed ID: 1870835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P; Farine JC; Barras JP
    Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caclium dobesilate in diabetic retinopathy.
    Sévin R; Cuendet JF
    Ophthalmologica; 1969; 159(1):126-35. PubMed ID: 5369367
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical study of calcium dobesilate in the treatment of cerebral circulatory insufficiency. Apropos of 30 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Oct; 19(8 Suppl 3):886-9. PubMed ID: 4618592
    [No Abstract]   [Full Text] [Related]  

  • 47. A double-blind trial of calcium dobesilate in chronic venous insufficiency.
    Casley-Smith JR
    Angiology; 1988 Oct; 39(10):853-7. PubMed ID: 3177951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives on the prevention of diabetic microangiopathy. Clinical pharmacological study].
    Guerrini M; Pieragalli D; Acciavatti A; Galigani C; Guideri F; Franchi M; Landini F; Burresi A; Messa GL; Frigerio C
    Clin Ter; 1989 May; 129(4):271-85. PubMed ID: 2527121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The diabetic retinopathy in the ophthalmologic practice (author's transl)].
    Zielinski HW
    Klin Monbl Augenheilkd; 1975 Nov; 167(5):715-9. PubMed ID: 1206953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The action of calcium dobesilate in diabetic retinopathy].
    Sevin R; Cuendet JF
    Bull Mem Soc Fr Ophtalmol; 1969; 82():170-80. PubMed ID: 5402400
    [No Abstract]   [Full Text] [Related]  

  • 51. Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
    Javadzadeh A; Ghorbanihaghjo A; Adl FH; Andalib D; Khojasteh-Jafari H; Ghabili K
    Mol Vis; 2013; 19():62-8. PubMed ID: 23335852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
    Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
    Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current dimensions of ophthalmology].
    Kutschera E
    Wien Med Wochenschr; 1977 Nov; 127(21):652-5. PubMed ID: 930107
    [No Abstract]   [Full Text] [Related]  

  • 54. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of diabetic retinopathy and recurrent hemorrhages into the vitreous with calcium dobesilate].
    Favre M
    Ophthalmologica; 1970; 161(4):389-93. PubMed ID: 5483904
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcium dobesilate: A drug treatment for diabetic retinopathy can negatively interfere with the measurement of glycated albumin using the enzymatic method.
    Guo X; Zhao F; Yin Y; Wang D; Hou L; Wu J; Li D; Cheng X; Xia L; Xu E; Qiu L
    Clin Chim Acta; 2018 Aug; 483():1-5. PubMed ID: 29653084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The action of calcium dobesilate on capillary permeability in diabetics.
    Sévin R; Cuendet JF
    Ophthalmologica; 1971; 162(1):33-40. PubMed ID: 5547865
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial.
    Schram MT; Stam F; de Jongh RT; de Vries G; van Dijk RA; Serné EH; Lampe D; Nanayakkara PW; Tushuizen ME; Scheffer PG; Schalkwijk CG; Kamper AM; Stehouwer CD
    Atherosclerosis; 2003 Sep; 170(1):59-72. PubMed ID: 12957683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H; Guo L
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):56-8. PubMed ID: 9868029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina.
    Szabo ME; Haines D; Garay E; Chiavaroli C; Farine JC; Hannaert P; Berta A; Garay RP
    Eur J Pharmacol; 2001 Oct; 428(2):277-86. PubMed ID: 11675046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.